Healthcare: Air Liquide reinforces its presence in Europe with the acquisition of Medidis in the Netherlands

Air Liquide is pursuing the development of its Healthcare business in Europe with the acquisition of Medidis, a major player in the Netherlands for the treatment of respiratory diseases at home and the production and supply of medical oxygen. With this acquisition, Air Liquide, leader in home healthcare in Europe and present in the home healthcare market in the Netherlands for more than 20 years, strengthens its position in a growing market.  

Medidis is a nationwide player that provides home healthcare support for patients suffering from respiratory failure and sleep apnea. Medidis supplies medical oxygen to patients being treated at home as well as those receiving care in assisted living facilities and to healthcare professionals who work outside the hospital setting. It also operates a medical oxygen production facility.

Present for more than 25 years in the Dutch market, Medidis employs more than 70 people and generated revenue of approximately 11 million euros in 2017. This acquisition both reinforces and diversifies Air Liquide’s existing healthcare offering and allows the Group to directly serve more than 26,000 additional patients in this country. Air Liquide will work with the existing teams to pursue the development of these businesses.

Already present in the Netherlands, Air Liquide will be able to leverage the complementarity of Medidis in both geographic and therapeutic terms. Concerning home healthcare, this acquisition will reinforce the Group’s position in the support of patients who suffer from respiratory failure. Moreover, it will increase its customer base  with healthcare professionals who work outside the hospital (such as medical homes or ambulances). Air Liquide will also benefit from Medidis' established relationships with doctors, hospitals, and insurers in new regions and from an increased production capacity, which will allow the Group to further develop healthcare activities in the Netherlands.

François Jackow​, member of the Air Liquide Executive Committee, supervising Healthcare activities stated:

“This acquisition gives Air Liquide an added dimension in the Dutch market. We are delighted to welcome the Medidis teams, recognized for their expertise in the treatment of respiratory diseases and their knowledge of the Dutch market, both at home and the growing market for the supply of medical oxygen outside the hospital. Air Liquide thus continues its momentum in terms of strengthening its positions in Europe, which is key to our strategy of developing the Healthcare business.”